@article{a0c8c02d843d4411a5838055744a7c42,
title = "Depression and diabetes: Treatment and health-care delivery",
abstract = "Despite research efforts in the past 20 years, scientific evidence about screening and treatment for depression in diabetes remains incomplete and is mostly focused on North American and European health-care systems. Validated instruments to detect depression in diabetes, although widely available, only become effective and thus recommended if subsequent treatment pathways are accessible, which is often not the case. Because of the well known adverse effects of the interaction between depression and diabetes, treatment goals should focus on the remission or improvement of depression as well as improvement in glycaemic control as a marker for subsequent diabetes outcome. Scientific evidence evaluating treatment for depression in type 1 and type 2 diabetes shows that depression can be treated with moderate success by various psychological and pharmacological interventions, which are often implemented through collaborative care and stepped-care approaches. The evidence for improved glycaemic control in the treatment of depression by use of selective serotonin reuptake inhibitors or psychological approaches is conflicting; only some analyses show small to moderate improvements in glycaemic control. More research is needed to evaluate treatment of different depression subtypes in people with diabetes, the cost-effectiveness of treatments, the use of health-care resources, the need to account for cultural differences and different health-care systems, and new treatment and prevention approaches.",
keywords = "antidepressant agent, citalopram, fluoxetine, imipramine, magnesium, paroxetine, placebo, serotonin uptake inhibitor, sertraline, vitamin D, antidiabetic agent, Beck Depression Inventory, Center for Epidemiological Studies Depression Scale, clinical effectiveness, clinical practice, cognitive therapy, cost effectiveness analysis, cultural anthropology, depression, developing country, diabetes mellitus, differential diagnosis, disease association, disease course, disease severity, drug efficacy, drug safety, DSM-IV-TR, evidence based medicine, glycemic control, health care delivery, health care quality, Hospital Anxiety and Depression Scale, human, insulin dependent diabetes mellitus, non insulin dependent diabetes mellitus, patient counseling, Patient Health Questionnaire, practice guideline, priority journal, psychoeducation, psychologic assessment, psychopharmacology, randomized controlled trial (topic), remission, Review, screening, Structured Clinical Interview for DSM Disorders, suicidal ideation, supplementation, treatment indication, treatment planning, adult, aged, comorbidity, cooperation, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, female, male, mass screening, middle aged, psychology, public relations, socioeconomics, treatment outcome, trends, very elderly, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Comorbidity, Cooperative Behavior, Culture, Delivery of Health Care, Depression, Female, Humans, Hypoglycemic Agents, Interprofessional Relations, Male, Mass Screening, Middle Aged, Socioeconomic Factors, Treatment Outcome",
author = "Frank Petrak and Harald Baumeister and Skinner, {Timothy C.} and Alex Brown and Holt, {Richard I G}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/S2213-8587(15)00045-5",
language = "English",
volume = "3",
pages = "472--485",
journal = "The Lancet Diabetes and Endocrinology",
issn = "2213-8587",
publisher = "The Lancet Publishing Group",
number = "6",
}